Chargement en cours...
Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses’ Health Study
PURPOSE: Ki67 is a proliferation marker commonly assessed by immunohistochemistry in breast cancer, and it has been proposed as a clinical marker for subtype classification, prognosis and prediction of therapeutic response. However, the clinical utility of Ki67 is limited by the lack of consensus on...
Enregistré dans:
| Publié dans: | Breast Cancer Res Treat |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6995281/ https://ncbi.nlm.nih.gov/pubmed/28791482 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4421-3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|